The Cooper Companies Inc. (US) and Cook Group (US) are the Prominent Players in the In Vitro Fertilization /IVF Market
The global in vitro fertilization (IVF) market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% during the forecast period. Rise in the median age of first-time mothers, the declining fertility rate, increase awareness about the availability of IVF treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years
Some of the prominent players operating in the global infertility treatment market include The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany).
To know about the assumptions considered for the study download the pdf brochure
The analysis of market developments between 2018 and 2021 revealed that several growth strategies such as research collaborations and partnerships were adopted by market players to strengthen their product portfolios and maintain a competitive position in the IVF market
THE COOPER COMPANIES, INC.
The Cooper Companies operates through two business units, namely, CooperVision (CVI) and CooperSurgical (CSI). The company offers a wide range of products and services focused on women’s health, fertility, and diagnostics through its CooperSurgical business segment. This business unit markets its products under various brand names, such as ORIGIO (provides in vitro fertilization (IVF) products), Reprogenetics (provides genetic testing solutions), and LifeGlobal (providing media products as well as IVF laboratory air filtration products). Through offering a broad range of innovative technologies and services to clinicians and patients worldwide, the company aims to further strengthen its position in the market, by pursuing the strategy of acquisitions.
The company commercializes its products in over 100 countries and has its presence across the US, Europe, and the RoW. Some of its major subsidiaries include CooperVision International Holding Company (UK), Ocular Sciences SAS (France), CooperSurgical, Inc. (US), CooperSurgical Holdings Ltd. (UK), Cooper Medical, Inc. (US), The Cooper Companies Global Holdings LP (UK), Research Instruments Ltd. (UK), and TCC Holdings S.a.r.l (Luxembourg).
COOK GROUP
Cook Group is one of the leading companies in the field of medical device manufacturing. The company offers a wide range of infertility treatment devices and has a significant market presence globally. Cook focuses on strengthening its market position by adopting growth strategies such as expansions and collaborations. Cook Group has its new state-of-the-art distribution center in Singapore, which caters to the growing demands across India, Taiwan, and Thailand. Cook has its sales and marketing offices all over the globe, and its production facilities are based in Limerick (Ireland) and Canton (US). The company’s notable subsidiaries include Cook Ltd. (UK), Sabin Corporation (US), Cook Vascular Incorporated (US), William Cook Europe ApS (Denmark), and Cook Medical Incorporated (US). The company primarily operates in Australia, Canada, Denmark, Ireland, and the US and distributes its products in 135 countries.
VITROLIFE
Vitrolife develops, manufactures, and markets instruments, systems, and cultivation media related to assisted reproduction techniques. The company offers a wide range of products for various procedures, such as sperm preparation, oocyte retrieval, conventional IVF, ICSI, embryo culture, embryo transfer, vitrification, and slow freezing. Vitrolife is one of the first companies to dispense IVF laboratories with high standard ready-to-use culture media. The company operates under one business unit—Fertility segment—which develops, produces, and markets nutrient solutions (media), products for cryopreservation, and advanced disposable instruments such as needles and pipettes, as well as offers the time-lapse technology for assisted reproduction.
FUJIFILM IRVINE SCIENTIFIC
FUJIFILM Irvine Scientific is a wholly owned subsidiary of FUJIFILM Holdings Corporation. It provides a wide range of innovative products in life sciences and medical media to assist advances in customer healthcare. The company also focuses on manufacturing reagents and medical devices for researchers and clinicians working in cell therapy & regenerative medicine, assisted reproductive technology & cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines.
The company has manufacturing facilities in the US and Japan, and exports its products across Asia, Europe, South America, Africa, and the Middle East.
THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific is one of the leading players in the field of healthcare diagnostics and life science research. The company has a robust product portfolio in the life science solutions market. Thermo Fisher also has a strong market presence globally, with a sales and distribution network in more than 50 countries. The company focuses on strengthening its market position in the in vitro fertilization market mainly by adopting organic growth strategies, such as product development and commercialization. Thermo Fisher acquired Life Technologies (US), thus expanding its presence across various geographies. This helped the company to strengthen its position and expand its revenue in the in vitro fertilization market.
Related Reports:
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecast to 2026